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ABSTRACT: Hypoxemia is anticipated during wildlife anesthesia and thus should be prevented. We
evaluated the efficacy of low flow rates of supplemental oxygen for improvement of arterial
oxygenation in anesthetized brown bears (Ursus arctos). The study included 32 free-ranging brown
bears (yearlings, subadults, and adults; body mass 12–250 kg) that were darted with medetomidine-
zolazepam-tiletamine (MZT) from a helicopter in Sweden. During anesthesia, oxygen was
administered intranasally from portable oxygen cylinders at different flow rates (0.5–3 L/min).
Arterial blood samples were collected before (pre-O2), during, and after oxygen therapy and
immediately processed with a portable analyzer. Rectal temperature, respiratory rate, heart rate,
and pulse oximetry-derived hemoglobin oxygen saturation were recorded. Intranasal oxygen
supplementation at the evaluated flow rates significantly increased the partial pressure of arterial
oxygen (PaO2) from pre-O2 values of 9.161.3 (6.3–10.9) kPa to 20.466.8 (11.1–38.7) kPa during
oxygen therapy. When oxygen therapy was discontinued, the PaO2 decreased to values not
significantly different from the pre-O2 values. In relation to the body mass of the bears, the
following oxygen flow rates are recommended: 0.5 L/min to bears ,51 kg, 1 L/min to bears 51–
100 kg, 2 L/min to bears 101–200 kg, and 3 L/min to bears 201–250 kg. In conclusion, low flow rates
of intranasal oxygen were sufficient to improve arterial oxygenation in brown bears anesthetized
with MZT. Because hypoxemia quickly recurred when oxygen was discontinued, oxygen
supplementation should be provided continuously throughout anesthesia.
Key words: Anesthesia, brown bear, flow rate, hypoxemia, immobilization, oxygen therapy,
wildlife.
INTRODUCTION
Impaired oxygenation during anesthesia
can lead to morbidity and mortality during
and after the anesthetic event. Most
physiologic studies that include blood gas
analysis demonstrate hypoxemia with the
drugs and doses used for anesthesia in
free-ranging and captive wild animals
(Read 2003; Mich et al. 2008; Fahlman
et al. 2012). Mild to marked hypoxemia
has been documented in free-ranging and
captive brown bears (Ursus arctos) anes-
thetized with medetomidine-zolazepam-
tiletamine (MZT; Fahlman et al. 2011).
Hypoxemia is anticipated and thus should
be prevented during wildlife anesthesia.
Intranasal oxygen supplementation is a
simple and efficient method to increase
arterial oxygenation, as documented in
some wildlife species (Cattet et al. 2003;
Fahlman et al. 2010, 2012). In brown bears,
the use of intranasal oxygen at flow rates as
high as 6–10 L/min has been reported
(Mortenson and Bechert 2001; Cattet et al.
2003). Lower flow rates (2–5 L/min)
efficiently treated hypoxemic brown bears
on the basis of arterial blood gas analysis
(Fahlman et al. 2010), but optimal flow
rates to maintain adequate arterial oxygen-
ation have not been established.
Oxygen sources used in the field include
oxygen cylinders that store gaseous oxygen
under high pressure and portable battery-
driven oxygen concentrators that extract
nitrogen from the air and produce oxygen
on site (Fahlman et al. 2010, 2012). Small
light-weight oxygen cylinders are easy to
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carry during fieldwork, but refilling cylin-
ders may entail complex logistics in
remote areas. Thus, administration of the
minimum effective flow rate will reduce
the number of oxygen cylinders needed
and decrease costs. We evaluated the
efficacy of low flow rates of intranasal
oxygen for improvement of arterial oxy-
genation in anesthetized brown bears. We
also evaluated the effect of discontinued
oxygen therapy on arterial oxygenation.
MATERIALS AND METHODS
The study included 32 free-ranging brown
bears (Table 1) anesthetized for individual
marking for ecologic studies in the Scandina-
vian Brown Bear Research Project. The brown
bears were anesthetized in the county of
Dalarna, Sweden (approximately 61uN, 15uE)
in April 2006–2012. For anesthesia, medeto-
midine was used at a mean 6 SD (range) dose
of 0.1060.04 (0.05–0.23) mg/kg (DomitorH
vet., 1 mg/mL, or Zalopine, 10 mg/mL, Orion
Pharma Animal Health, Espoo, Finland) in
combination with zolazepam-tiletamine at
4.761.6 (2.3–9.1) mg/kg (Zoletil forte vet.,
Virbac S.A., Carros, France). All animals were
darted from a helicopter. A detailed descrip-
tion of the capture method, monitoring, and
physiologic responses during anesthesia of
brown bears with this drug combination has
been published (Fahlman et al. 2011). Ap-
proval was given by the Ethical Committee on
Animal Experiments in Uppsala, Sweden.
Blood sampling, analysis, and
physiologic monitoring
Arterial blood samples were collected an-
aerobically from the femoral artery before
(pre-O2, n531), during (n532), and after
(post-O2, n511) intranasal oxygen therapy.
Time of sampling varied depending on indi-
vidual procedures in the field. The second
sample was collected 1866 (7–40) min after
initiation of oxygen supplementation. The
post-O2 sample was collected 966 (3–25) min
after discontinued oxygen supplementation
and removal of the nasal line(s). All samples
were collected in preheparinized syringes,
capped, and immediately processed with the
use of a portable analyzer and cartridges (i-
STATH1 Portable Clinical Analyzer and i-
STATH cartridges CG4+, Abbott Laboratories,
Abbott Park, Illinois, USA). The analyses
included measured values for partial pressures
of oxygen (PaO2) and carbon dioxide (PaCO2),
pH, and lactate, and a calculated value for
arterial hemoglobin oxygen saturation (SaO2).
Rectal temperature, respiratory rate, and heart
rate were recorded at the time of arterial
sampling, and if feasible, pulse oximetry-
derived hemoglobin oxygen saturation (SpO2)
was also recorded. The pulse oximeter probe
was attached to the tongue (Nellcor NPB-40
handheld pulse oximeter, Nellcor Inc., Plea-
santon, California, USA). Blood gas values
were corrected to the rectal temperature,
except in one hyperthermic bear that received
a cold-water enema, which influenced the
accuracy of rectal temperature measurements.
For this bear, blood gases and pH at standard
temperature (37 C) were used.
Oxygen therapy and target PaO2
Oxygen was supplemented from portable
oxygen cylinders via one or two nasal lines
inserted 2–10 cm into the nasal cavity of the
bears. Light-weight aluminum cylinders with a
pressure regulator and flowmeter were used.
Initially, a flow rate of 2 L/min provided to
seven bears, independent of their body mass,
resulted in various degrees of hyperoxemia
(PaO2 range 14.5–38.7 kPa; 109–290 mmHg;
Fahlman et al. 2010). Thereafter, the flow rate
was adjusted based on body mass to approach
the minimum required flow rate necessary to
meet a target PaO2. Calculation of the target
PaO2 has been described (Fahlman et al.
2012). The target PaO2 represents the esti-
mated PaO2 value that could be expected in a
TABLE 1. Animal data and intranasal oxygen flow rates for 32 free-ranging brown bears (Ursus arctos)
included in a study on low flow oxygen therapy during anesthesia.
Age
na
Body mass (kg)
O2 flow rate
M F L/min mL/min per kilogram
Adult 11 7 60–250 1–3 9–28
Subadult 1 3 28–65 1–2 16–36
Yearling 6 4 12–25 0.5–2 20–167
a n 5 number of animals; M 5 male; F 5 female.
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normal awake brown bear at the altitude of
each capture site. Using local barometric
pressure for each individual, the resulting
target PaO2 ranged from 10.1 to 11.6 kPa
(mean 11.1 kPa) [76–87 mmHg (mean
83 mmHg)]. Brown bears were considered
hypoxemic if their PaO2 was below their
calculated target value. Normoxemic bears
with increased rectal temperatures ($39.7 C)
received intranasal oxygen therapy as part of
the treatment protocol for hyperthermia.
Statistical analysis
Physiologic values measured before and
during oxygen therapy were compared with a
two-tailed t-test. A one-way, repeated mea-
sures analysis of variance followed by a post
hoc Bonferroni’s multiple comparison test was
used for animals with PaO2 data available pre-,
during and post-O2 therapy. All analyses were
performed with GraphPad Prism (GraphPad
Software Inc., La Jolla, California, USA). A P-
value #0.05 was considered significant. Data
are presented as mean 6 SD (range).
RESULTS
Arterial oxygenation increased signifi-
cantly during oxygen supplementation
(Fig. 1). Of the 31 bears that were
sampled before oxygen therapy was initi-
ated, 25 bears were hypoxemic and six
bears were normoxemic. In the hypoxemic
bears, pre-O2 values of PaO2 increased
significantly from 9.161.3 (6.3–10.9) kPa
to 20.466.8 (11.1–38.7) kPa during oxygen
therapy [68610 (47–82) mmHg to
153651 (83–290) mmHg] (Fig. 1), and
the PaO2 reached or increased above the
calculated target PaO2 in all. The SaO2
increased significantly from 8666% (71–
94%) to 9862% (93–100%) during oxygen
therapy (n525). The SpO2 increased
significantly 8666% (75–93%) to 9165%
(82–97%) during oxygen therapy (n517).
In the six normoxemic bears that
received intranasal oxygen as part of
treatment of hyperthermia (rectal temper-
ature 39.7–40.8 C), the PaO2 increased
significantly from pre-O2 values of
11.760.7 (11.1–13.1) kPa to 16.964.3
(9.9–22.3) kPa during oxygen therapy
[8865 (83–98) mmHg to 127632 (74–
167) mmHg]. In one of these bears (adult
male, 111 kg), the PaO2 decreased from
11.1 kPa to 9.9 kPa (83 mmHg to
74 mmHg) during oxygen supplementa-
tion at 2 L/min.
The PaO2 response to the administered
oxygen flow rates showed wide interindi-
vidual variability (Fig. 2). The lowest flow
rate of 0.5 L/min was evaluated in bears
weighing from 14 to 25 kg, whereas 1 L/
min was used in bears weighing up to
102 kg, and 2 L/min in bears up to 230 kg
(Fig. 2). The heaviest bear in the study
weighed 250 kg and received 3 L/min
initially, followed by an increase to 5 L/
min. Based on actual body weights, in
bears receiving oxygen at a flow rate of 10–
20 mL/min per kilogram, the PaO2 ranged
from 9.9 to 22.1 kPa (74–166 mmHg), and
in bears receiving 22–133 mL/min per
kilogram, the PaO2 ranged from 11.1 to
38.7 kPa (83–290 mmHg).
In the 11 bears for which data were
available pre-, during, and post-O2, the
PaO2 increased significantly during oxygen
supplementation (Fig. 3). When oxygen
therapy was discontinued, the PaO2 de-
creased significantly to values that were
not significantly different from the pre-O2
values (Fig. 3).
FIGURE 1. Partial pressure of arterial oxygen
(PaO2) before (pre-O2) and during intranasal oxygen
therapy (0.5–3 L/min) administered from a portable
oxygen cylinder to 25 anesthetized brown bears
(Ursus arctos) that were hypoxemic before oxygen
therapy was instituted. The whiskers represent
minimum and maximum values, and the asterisk
indicates a significant difference (P,0.05) from the
previous sample. The dotted line represents the
mean target PaO2 of 11.1 kPa (individual range 10.1–
11.6 kPa).
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The PaCO2 increased significantly from
pre-O2 values of 5.660.8 (0.1–8.3) kPa to
6.360.9 (4.8–9.9) kPa during oxygen therapy
[4266 (31–62) mmHg to 4767 (36–74)
mmHg] (n531). Mild hypercapnia was
recorded in seven bears before, during, and
after oxygen therapy (PaCO2 6.1–6.7 kPa;
46–50 mmHg). In 10 additional bears, a mild
hypercapnia was recorded during oxygen
therapy only (PaCO2 6.1–7.3 kPa; 46–
55 mmHg). Marked hypercapnia was re-
corded only in one bear, both before and
during oxygen therapy (PaCO2 8.3 and
9.9 kPa; 62 and 74 mmHg, respectively).
Heart rate decreased significantly from pre-
O2 values of 73618 (36–110) beats/min to
68616 (32–100) beats/min during oxygen
therapy (n530). Lactate decreased signifi-
cantly from pre-O2 values of 5.763.4 (1.7–
13.0) mmol/L to 3.161.7 (0.8–7.3) mmol/L
during oxygen therapy (n531). There was no
significant change in respiratory rate [pre-O2
1169 (3–48) breaths/min, n531], rectal
temperature [pre-O2 39.361.0 C (37.4–
41.3 C), n530], or pH [pre-O2 7.2760.06
(7.12–7.40), n531].
The pulse oximetry-derived hemoglobin
saturation values (SpO2) were lower than
the SaO2 in 20 of 21 paired measurements
during oxygen supplementation. In eight
paired measurements, SpO2 values #90%
were recorded, whereas all SaO2 values
were $95% in all 21 bears.
DISCUSSION
Low flow oxygen therapy efficiently
treated hypoxemia in anesthetized brown
FIGURE 2. Partial pressure of arterial oxygen
(PaO2) in anesthetized brown bears (Ursus arctos)
supplemented with different flow rates of intranasal
oxygen from portable oxygen cylinders. All bears
included in this figure were hypoxemic before oxygen
therapy was initiated. The flow rate was progressively
adjusted between individuals to approach the min-
imum effective flow rate to meet an individual target
PaO2 ranging from 10.1 to 11.6 kPa. The dotted line
represents the mean target PaO2 of 11.1 kPa.
FIGURE 3. Partial pressure of arterial oxygen
(PaO2, mean 6 SD) before (pre-O2), during, and
after (post-O2) intranasal oxygen therapy adminis-
tered at 0.5–3 L/min from a portable oxygen cylinder
to 11 anesthetized brown bears (Ursus arctos). The
asterisk indicates a significant difference (P,0.05)
from the pre- and post-O2 samples. The dotted line
represents the mean target PaO2 of 11.1 kPa
(individual range 10.1–11.6 kPa).
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bears. Flow rates from 0.5 to 3 L/min
markedly improved arterial oxygenation in
the study bears, which had a body mass
from 12 to 250 kg. The goal of oxygen
therapy in the hypoxemic bears was to
increase arterial oxygenation to reach a
calculated target PaO2, representing the
assumed normal level. The oxygen flow
rates were gradually reduced between
individuals, according to the arterial blood
gas results, to see whether minimum
effective flow rates could be established
for different sized bears. Based on actual
body weights of the brown bears in this
study, we recommend intranasal supple-
mentation at a flow rate of approximately
10–20 mL/min per kilogram. Similarly,
low oxygen flow rates (14–18 mL/min per
kilogram) effectively treated hypoxemic
white-tailed deer when supplemented
intranasally with oxygen at 1 L/min (Fahl-
man et al. 2014). For simplicity in the
field, a quick chart for oxygen flow rates
has been established for brown bears
anesthetized with MZT: 0.5 L/min to
bears ,50 kg, 1 L/min to bears 51–
100 kg, 2 L/min to bears 101–200 kg,
and 3 L/min to bears 201–250 kg. It is
possible that even lower flow rates may be
adequate, depending on the individual
response to oxygen therapy.
Use of the minimum effective flow rate
will decrease cost by reducing the number
of oxygen cylinders and the logistics in-
volved in refilling oxygen cylinders, which
also is time consuming during remote
fieldwork. A further advantage is a consid-
erable space and weight reduction in the
amount of equipment needed in the field,
when lower flow rates and thus fewer
oxygen cylinders can be used. Based on
the current study, the low flow of 0.5 L/min
recommended for brown bears weighing up
to 50 kg will make a D-cylinder that
contains 425 L of oxygen last for 14.2 hr.
In comparison, it will only last 1.2 hr at a
flow rate of 6 L/min, and 0.7 hr at 10 L/min,
which are the previously published flow
rates used in brown bears (Mortenson and
Bechert 2001; Cattet et al. 2003).
The wide individual variation in PaO2
between bears receiving the same oxygen
flow rate may be due to differences in
breathing pattern, ventilatory minute vol-
ume, and depth of anesthesia. In general,
increasing the oxygen flow rate increases
the fraction of inspired oxygen (FIO2) and
the PaO2, but individual variation has also
been shown in dogs (Canis lupus famil-
iaris; Fitzpatrick and Crowe 1986). Un-
necessary high FIO2 can lead to resorption
atelectasis, which causes increased intra-
pulmonary shunting, as shown in humans
and horses (Nyman et al. 1990; Edmark
et al. 2003; Marntell et al. 2005). Inap-
propriate high flow oxygen therapy com-
monly results in hyperoxia (abnormally
high oxygen content in tissues and organs),
but oxygen toxicity depends on both the
oxygen dose (i.e., the concentration deliv-
ered; FIO2) and the duration of treatment.
With intranasal administration of oxygen
the FIO2 does not reach possible toxicity
levels, and wild animals are rarely anes-
thetized for prolonged periods. Neverthe-
less, the lowest FIO2 possible should be
used to achieve normoxemia and to
prevent hypoxemia and hyperoxemia (su-
pranormal PaO2). Measurement of the
FIO2 requires a gas analyzer and place-
ment of a tracheal catheter, which makes
it unfeasible in field situations; thus, FIO2
values in anesthetized wildlife are seldom
reported.
Our second aim was to evaluate the
effect of discontinued oxygen therapy on
arterial oxygenation, because the benefi-
cial increases in PaO2 and FIO2 associated
with oxygen administration diminish rap-
idly when oxygen is discontinued (Dunphy
et al. 2002). In dogs the FIO2 falls to
baseline within 10 sec when oxygen
therapy is interrupted (Fitzpatrick and
Crowe 1986). In the current study,
hypoxemia resumed when oxygen supple-
mentation was interrupted, as also de-
scribed in other wildlife species such as
white-tailed deer (Odocoileus virginianus)
and bongo antelope (Tragelaphus eury-
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cerus; Schumacher et al. 1997; Fahlman et
al. 2014). Thus, continuous oxygen sup-
plementation is imperative throughout
anesthesia.
In agreement with our results, blood gas
studies in other species of bears have also
demonstrated hypoxemia during anesthesia
with MZT (Caulkett and Cattet 1997;
Caulkett et al. 1999). Hypoxemia is often
clinically silent, and pulse oximetry can be
unreliable for detection of hypoxemia in
bears and other wildlife species (Schuma-
cher et al. 1997; Cattet et al. 1999; Mich
et al. 2008; Fahlman et al. 2010; Muller et al.
2012). Pulse oximetry underestimated he-
moglobin oxygen saturation during oxygen
therapy in all but one of the 21 paired
measurements of SaO2 and SpO2 from
brown bears in the present study. When
these subjects were breathing air, pre- or
post-O2 supplementation, SpO2 unpredict-
ably overestimated or underestimated the
saturation compared with SaO2. Because
pulse oximetry and clinical signs are insuf-
ficiently sensitive to ensure recognition of
hypoxemia, routine administration of oxygen
is recommended. However, previously rec-
ommended flow rates in published litera-
ture might not be optimal, or evaluated on
the basis of arterial blood gases. In brown
bears, flow rates of 6–10 L/min were
reported to increase hemoglobin oxygen
saturation based on pulse-oximetry (Cattet
et al. 2003). Another study reports that
brown bears supplemented with intra-
nasal oxygen at 6 L/min had relatively low
PaO2 values (mean6SE; 8.560.4 kPa;
6463 mmHg), possibly because of low body
temperatures or mixed venous-arterial sam-
ples when sampling sublingual vessels
(Mortenson and Bechert 2001). Flow rates
of 2–5 L/min resulted in hyperoxemia in
some brown bears, with PaO2 values up to
40.8 kPa (306 mmHg) (Fahlman et al. 2010).
Unnecessarily high flow rates are wasteful of
oxygen and less economical, and the only
advantage to the animal is increased time to
desaturation of the hemoglobin (Edmark
et al. 2003). Oxygen flow rates should
preferably be adjusted according to arterial
blood gas determinations.
Intranasal oxygen administration is a
practical and noninvasive method that is
simple to perform in the field. Nasal lines
were easily placed in the anesthetized
bears and should be secured close to the
nares to prevent displacement. Arterial
oxygenation improved whether unilateral
or bilateral lines were used for the bears,
as also demonstrated in dogs (Dunphy
et al. 2002). When comparing a specific
flow rate administered through one nasal
catheter to that same flow rate divided
between two nasal lines, there was no
difference in the PaO2 and the FIO2 in the
dog study (Dunphy et al. 2002).
In addition to treatment of hypoxemic
brown bears, intranasal oxygen was ad-
ministered as part of the treatment
protocol for hyperthermia to brown bears
with elevated rectal temperatures. It has
been shown in pigs (Sus scrofa) that nasal
flushing with oxygen induces a rapid, flow-
dependant decrease in brain temperature
(Einer-Jensen et al. 2001). Since both
hypoxemia and hyperthermia adversely
affect brain and nervous tissue, local
cooling of the nasal cavities with oxygen
aid in prevention of brain injury.
Although the mean PaCO2 increase was
statistically significant, the hypercapnia
was not considered clinically relevant.
Similar levels of hypercapnia and an
increase in PaCO2 over time during
anesthesia have been recorded in anes-
thetized bears that were not given oxygen
(Fahlman et al. 2011).
The adult male bear that was hypoxemic
(PaO2 8.7 kPa; 65 mmHg) despite oxygen
therapy at 3 L/min was tachypneic (70
breaths/min) and hyperthermic (40.9 C).
After treatment with a 0.5-L cold-water
enema, 1 L of intravenous fluids, and an
increased oxygen flow rate of 5 L/min, the
respiratory rate had decreased to 28
breaths/min and normoxemia was estab-
lished. The initial poor response in arterial
oxygenation to oxygen therapy in this bear
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was probably due to the rapid shallow
breathing pattern, with increased dead
space ventilation and decreased alveolar
ventilation, leading to an impaired venti-
lation/perfusion (V/Q) matching. An im-
paired V/Q mismatch can be treated with
increased oxygen concentration.
In conclusion, low flow rates of intra-
nasal oxygen were sufficient to improve
arterial oxygenation in anesthetized brown
bears. Intranasal administration is a prac-
tical and noninvasive method of oxygen
supplementation that is simple to perform
in the field. Oxygen supplementation
should be provided continuously through-
out anesthesia, because hypoxemia quickly
recurred when oxygen was discontinued.
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